Cell C listed on the JSE on Thursday, completing a multi-year turnaround that has reshaped the business.
Browsing: JSE
The rand and South African shares and bonds extended their rally on Thursday as investors cheered signs of fiscal discipline.
Cell C is heading to the public market with a proposed JSE listing that pegs the offer price between R29.50 and R35.50/share.
The Competition Commission has alleged that the JSE’s conduct has hampered the ability of rival exchange A2X to compete.
Cell C Holdings has announced its intention to list on the JSE, a move that had been expected for some time.
MultiChoice’s run as a public company is drawing to a close, with its ticker set to blink for the last time on 10 December.
Optasia’s plans to list on the JSE could see the company valued at up to R23.5-billion in its public market debut.
JSE CEO Leila Fourie is to retire early next year and will be succeeded by Valdene Reddy.
Optasia, a fintech company partly owned by Ethos Capital, plans to list on the JSE and raise up to R6.3-billion.
A key regulator has given the green light to a transaction that should help advance a proposed plan to list Cell C.